These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 35377943
1. Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals. Parcha V, Malla G, Irvin MR, Armstrong ND, Judd SE, Lange LA, Maurer MS, Levitan EB, Goyal P, Arora G, Arora P. JAMA; 2022 Apr 12; 327(14):1368-1378. PubMed ID: 35377943 [Abstract] [Full Text] [Related]
2. Cardiovascular Disease and Mortality in Black Women Carrying the Amyloidogenic V122I Transthyretin Gene Variant. Haring B, Hunt RP, Shadyab AH, Eaton C, Kaplan R, Martin LW, Panjrath G, Kuller LH, Assimes T, Kooperberg C, Wassertheil-Smoller S. JACC Heart Fail; 2023 Sep 12; 11(9):1189-1199. PubMed ID: 36930136 [Abstract] [Full Text] [Related]
3. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry. Damrauer SM, Chaudhary K, Cho JH, Liang LW, Argulian E, Chan L, Dobbyn A, Guerraty MA, Judy R, Kay J, Kember RL, Levin MG, Saha A, Van Vleck T, Verma SS, Weaver J, Abul-Husn NS, Baras A, Chirinos JA, Drachman B, Kenny EE, Loos RJF, Narula J, Overton J, Reid J, Ritchie M, Sirugo G, Nadkarni G, Rader DJ, Do R. JAMA; 2019 Dec 10; 322(22):2191-2202. PubMed ID: 31821430 [Abstract] [Full Text] [Related]
4. The amyloidogenic V122I transthyretin variant in elderly black Americans. Quarta CC, Buxbaum JN, Shah AM, Falk RH, Claggett B, Kitzman DW, Mosley TH, Butler KR, Boerwinkle E, Solomon SD. N Engl J Med; 2015 Jan 01; 372(1):21-9. PubMed ID: 25551524 [Abstract] [Full Text] [Related]
5. Carpal Tunnel Syndrome and Transthyretin Amyloidosis in the All of Us Research Program. Shetty NS, Pampana A, Patel N, Maurer MS, Goyal P, Li P, Arora G, Arora P. Mayo Clin Proc; 2024 Jul 01; 99(7):1101-1111. PubMed ID: 38661598 [Abstract] [Full Text] [Related]
6. DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis. Akinboboye O, Shah K, Warner AL, Damy T, Taylor HA, Gollob J, Powell C, Karsten V, Vest J, Maurer MS. Amyloid; 2020 Dec 01; 27(4):223-230. PubMed ID: 32456532 [Abstract] [Full Text] [Related]
7. Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population. Kozlitina J, Garg S, Drazner MH, Matulevicius SA, Ayers C, Overton J, Reid J, Baras A, Rao K, Pandey A, Berry J, de Lemos JA, Grodin JL. J Card Fail; 2022 Mar 01; 28(3):403-414. PubMed ID: 34634447 [Abstract] [Full Text] [Related]
8. Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals. Hyacinth HI, Franceschini N, Seals SR, Irvin MR, Chaudhary N, Naik RP, Alonso A, Carty CL, Burke GL, Zakai NA, Winkler CA, David VA, Kopp JB, Judd SE, Adams RJ, Gee BE, Longstreth WT, Egede L, Lackland DT, Greenberg CS, Taylor H, Manson JE, Key NS, Derebail VK, Kshirsagar AV, Folsom AR, Konety SH, Howard V, Allison M, Wilson JG, Correa A, Zhi D, Arnett DK, Howard G, Reiner AP, Cushman M, Safford MM. JAMA Netw Open; 2021 Jan 04; 4(1):e2030435. PubMed ID: 33399855 [Abstract] [Full Text] [Related]
9. Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the US. Selvaraj S, Claggett BL, Quarta CC, Yu B, Inciardi RM, Buxbaum JN, Mosley TH, Shah AM, Dorbala S, Falk RH, Solomon SD. JAMA Cardiol; 2023 Aug 01; 8(8):784-788. PubMed ID: 37212191 [Abstract] [Full Text] [Related]
11. Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population. Greve AM, Christoffersen M, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A. JAMA Cardiol; 2021 Mar 01; 6(3):258-266. PubMed ID: 33237279 [Abstract] [Full Text] [Related]
12. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry. Parker MM, Damrauer SM, Tcheandjieu C, Erbe D, Aldinc E, Hawkins PN, Gillmore JD, Hull LE, Lynch JA, Joseph J, Ticau S, Flynn-Carroll AO, Deaton AM, Ward LD, Assimes TL, Tsao PS, Chang KM, Rader DJ, Fitzgerald K, Vaishnaw AK, Hinkle G, Nioi P. Sci Rep; 2021 Jun 02; 11(1):11645. PubMed ID: 34079032 [Abstract] [Full Text] [Related]
13. Cardiac Amyloidosis Due to Transthyretin Protein: A Review. Ruberg FL, Maurer MS. JAMA; 2024 Mar 05; 331(9):778-791. PubMed ID: 38441582 [Abstract] [Full Text] [Related]
14. Design and Rationale the SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. Ruberg FL, Blaner WS, Chiuzan C, Connors LH, Einstein AJ, Fine D, Helmke S, Kurian D, Pandey S, Raiszadeh F, Rodriguez C, Sabogal N, Teruya S, Winburn M, Chung WK, Cohn E, Miller EJ, Kelly JW, Maurer MS. J Am Heart Assoc; 2023 Apr 18; 12(8):e028534. PubMed ID: 37066788 [Abstract] [Full Text] [Related]
15. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B, Judge DP, Lenihan DJ, Gottlieb SS, Shah SJ, Steidley DE, Ventura H, Murali S, Silver MA, Jacoby D, Fedson S, Hummel SL, Kristen AV, Damy T, Planté-Bordeneuve V, Coelho T, Mundayat R, Suhr OB, Waddington Cruz M, Rapezzi C, THAOS Investigators. J Am Coll Cardiol; 2016 Jul 12; 68(2):161-72. PubMed ID: 27386769 [Abstract] [Full Text] [Related]
16. Low Prevalence of Clinically Apparent Cardiac Amyloidosis Among Carriers of Transthyretin V122I Variant in a Large Electronic Medical Record. Agbor-Etang BB, Okafor HE, Farber-Eger EH, Wells QS. Am J Med; 2021 Feb 12; 134(2):e98-e100. PubMed ID: 32866461 [Abstract] [Full Text] [Related]
17. Relation of Body Mass Index to Transthyretin Cardiac Amyloidosis Particularly in Black and Hispanic Patients (from the SCAN-MP Study). Poterucha TJ, Kurian D, Raiszadeh F, Teruya S, Elias P, Kogan R, Chiuzan C, Einstein AJ, Ruberg FL, Maurer MS. Am J Cardiol; 2022 Aug 15; 177():116-120. PubMed ID: 35705430 [Abstract] [Full Text] [Related]
18. Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults. Coniglio AC, Segar MW, Loungani RS, Savla JJ, Grodin JL, Fox ER, Garg S, de Lemos JA, Berry JD, Drazner MH, Shah S, Hall ME, Shah A, Khan SS, Mentz RJ, Pandey A. JACC Heart Fail; 2022 Feb 15; 10(2):129-138. PubMed ID: 35115086 [Abstract] [Full Text] [Related]
19. Association between urinary albumin excretion and coronary heart disease in black vs white adults. Gutiérrez OM, Khodneva YA, Muntner P, Rizk DV, McClellan WM, Cushman M, Warnock DG, Safford MM, REGARDS Investigators. JAMA; 2013 Aug 21; 310(7):706-14. PubMed ID: 23989654 [Abstract] [Full Text] [Related]
20. Stroke incidence and mortality trends in US communities, 1987 to 2011. Koton S, Schneider AL, Rosamond WD, Shahar E, Sang Y, Gottesman RF, Coresh J. JAMA; 2014 Jul 16; 312(3):259-68. PubMed ID: 25027141 [Abstract] [Full Text] [Related] Page: [Next] [New Search]